Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Astrocytic GAT-3 Modulates Synaptic Transmission and Memory
2026-05-15
A recent study demonstrates that astrocytic GAT-3 regulates synaptic transmission and contextual memory formation in the dentate gyrus by mediating astrocytic Ca2+ signaling and modulating excitatory input. These findings uncover a previously underexplored glial mechanism essential for cognitive processing and inform future neurotransmitter release modulation assays.
-
Biotin-16-UTP: Technical Guide for RNA Labeling Workflows
2026-05-14
Biotin-16-UTP is a biotin-labeled uridine triphosphate designed for efficient incorporation into RNA during in vitro transcription, enabling sensitive detection and purification via streptavidin or anti-biotin systems. It is well-suited for RNA-protein interaction studies, RNA localization assays, and related molecular biology workflows. This product should not be used for diagnostic or clinical applications.
-
Lyso-Tracker Red DND-99: Optimizing Lysosome Labeling in Liv
2026-05-14
Lyso-Tracker Red DND-99 delivers unmatched specificity for lysosome labeling in live-cell imaging, elevating both workflow reliability and experimental insight. This guide translates breakthrough research and expert troubleshooting into actionable protocols for advanced lysosomal analysis.
-
Triazole ALDH2 Activators for Myocardial Ischemia Protection
2026-05-13
A recent study introduces novel triazole-based ALDH2 activators with improved water solubility and potent activity, significantly mitigating myocardial ischemia-reperfusion injury in preclinical models. These findings provide a foundation for the development of targeted therapies addressing ALDH2 dysfunction, particularly in populations at heightened risk for myocardial infarction.
-
Dovitinib (TKI-258): Applied Workflows for RTK-Driven Cancer
2026-05-13
Dovitinib (TKI-258, CHIR-258) empowers translational oncology with robust, multitargeted RTK inhibition, enabling reproducible apoptosis and signaling pathway interrogation across cancer models. This article delivers actionable, evidence-backed workflows, troubleshooting strategies, and advanced applications to maximize the impact of Dovitinib in apoptosis induction and pathway-specific assays.
-
BFH772 (VEGFR2 inhibitor): Technical Use and Protocol Guidan
2026-05-12
BFH772 is a highly selective VEGFR2 inhibitor optimized for targeted disruption of VEGFR2-mediated angiogenesis, especially in tumor model research. It is not suitable for workflows requiring water solubility or broad-spectrum kinase inhibition due to its defined solubility and selectivity profiles.
-
Resiniferatoxin (RTX): Advancing Pain Models & TRPV1 Researc
2026-05-12
Resiniferatoxin (RTX) sets a new standard for selective TRPV1 activation, enabling ultra-potent and long-lasting sensory neuron desensitization in preclinical pain models. This article maps out optimized workflows, troubleshooting strategies, and actionable insights—grounded in the latest reference findings—to help researchers extract maximum value from RTX experiments.
-
Panobinostat Drives Calcineurin Degradation in Multiple Myel
2026-05-11
This study reveals that the histone deacetylase inhibitor panobinostat targets calcineurin (PPP3CA) for degradation, reducing multiple myeloma cell viability and enhancing the efficacy of combination therapies. These findings highlight a novel molecular vulnerability in refractory multiple myeloma and suggest new avenues for overcoming drug resistance.
-
FITC Goat Anti-Rabbit IgG (H+L) Antibody: Precision in Bioma
2026-05-11
The FITC Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive and reproducible detection of rabbit primary antibodies in advanced immunoassays. Its robust signal amplification and low background support high-impact translational workflows, from biomarker discovery to quantitative proteomics.
-
Sulfo-Cy5 Carboxylic Acid: Precision Fluorescence for Intest
2026-05-10
Explore how Sulfo-Cy5 carboxylic acid, a leading fluorescent dye for life sciences, uniquely empowers intestinal immunity and mucosal vaccine studies. Discover advanced scientific insights and protocol guidance distinct from prior content.
-
WZ4003: Enhancing Cell Assay Reliability with Selective NUAK
2026-05-09
This article provides a scenario-driven, evidence-based guide to leveraging WZ4003 (SKU B1374), a potent and selective NUAK1/2 inhibitor, in advanced cell viability and migration assays. Researchers will find practical strategies for optimizing experimental design, data interpretation, and reagent selection, ensuring reproducibility and translational relevance in cancer and neurodegeneration studies.
-
Berberrubine Modulates Vitamin K Cycle to Inhibit Thrombosis
2026-05-08
This study demonstrates that berberrubine, a major metabolite of berberine, significantly inhibits thrombosis in a mouse model by modulating the vitamin K catalytic cycle. Through integrated metabolomics and molecular docking, the authors identify vitamin K epoxide reductase and γ-glutamyl carboxylase as key molecular targets, providing mechanistic insight and a foundation for safer antithrombotic drug development.
-
LINC02870 Enhances SNAIL Translation in Hepatocellular Carci
2026-05-08
The referenced study reveals that overexpression of the long non-coding RNA LINC02870 promotes hepatocellular carcinoma (HCC) progression by facilitating SNAIL translation via interaction with EIF4G1. This mechanistic insight underscores LINC02870 as a potential prognostic marker and therapeutic target in HBV-related HCC.
-
NSC-23766: Precision Rac GTPase Inhibition for Cancer Resear
2026-05-07
NSC-23766 trihydrochloride offers bench scientists a highly selective tool to dissect Rac1 signaling, modulate apoptosis, and control cell cycle progression, with demonstrated efficacy in breast cancer models. This article details applied workflows, troubleshooting strategies, and lessons from recent metabolic research to maximize reproducibility and insight.
-
Biotin-16-UTP for Precise Biotin-Labeled RNA Synthesis Workf
2026-05-07
Biotin-16-UTP addresses the need for specific, high-yield labeling of RNA with biotin during in vitro transcription, enabling targeted RNA purification, detection, and interaction studies. It is not suitable for diagnostic or medical applications and is recommended only for controlled laboratory protocols requiring biotin-labeled uridine triphosphate.